Search research articles
Contact Us
Filters
Showing results (171-180 of 183) with videos related to
Page
of 19
Sort By:
Cell Reports
|
December 22, 2015
Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis
Rajesha Rupaimoole, Jaehyuk Lee, Monika Haemmerle, et al.
Molecular Oncology
|
March 14, 2023
Disclosing quantitative RT-PCR raw data during manuscript submission: a call for action
Andreas Untergasser, Jan Hellemans, Michael W Pfaffl, et al.
Haematologica
|
December 20, 2024
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome
Serena De Matteis, Laura Del Coco, Federica De Castro, et al.
Haematologica
|
April 23, 2026
Pre-treatment circulating microRNA signatures predict outcomes of anti-CD19 CAR T-cell therapy
Maria Naddeo, Roberta Roncarati, Francesco De Felice, et al.
Nature Communications
|
November 29, 2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs
Ivan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Journal of Extracellular Vesicles
|
March 12, 2020
Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells
Emanuela Mensà, Michele Guescini, Angelica Giuliani, et al.
Nature Communications
|
January 10, 2018
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs
Ivan Vannini, Petra M Wise, Kishore B Challagundla, et al.
The Journal of Clinical Investigation
|
June 4, 2024
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells
Gianluca Storci, Francesco De Felice, Francesca Ricci, et al.
The Journal of Clinical Investigation
|
June 1, 2023
Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response
Mihnea P Dragomir, Enrique Fuentes-Mattei, Melanie Winkle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2016
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
Katrien Van Roosbroeck, Francesca Fanini, Tetsuro Setoyama, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 183) with videos related to
Sort By:
Page
of 19
Cell Reports
|
December 22, 2015
Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis
Rajesha Rupaimoole, Jaehyuk Lee, Monika Haemmerle, et al.
Molecular Oncology
|
March 14, 2023
Disclosing quantitative RT-PCR raw data during manuscript submission: a call for action
Andreas Untergasser, Jan Hellemans, Michael W Pfaffl, et al.
Haematologica
|
December 20, 2024
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome
Serena De Matteis, Laura Del Coco, Federica De Castro, et al.
Haematologica
|
April 23, 2026
Pre-treatment circulating microRNA signatures predict outcomes of anti-CD19 CAR T-cell therapy
Maria Naddeo, Roberta Roncarati, Francesco De Felice, et al.
Nature Communications
|
November 29, 2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs
Ivan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Journal of Extracellular Vesicles
|
March 12, 2020
Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells
Emanuela Mensà, Michele Guescini, Angelica Giuliani, et al.
Nature Communications
|
January 10, 2018
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs
Ivan Vannini, Petra M Wise, Kishore B Challagundla, et al.
The Journal of Clinical Investigation
|
June 4, 2024
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells
Gianluca Storci, Francesco De Felice, Francesca Ricci, et al.
The Journal of Clinical Investigation
|
June 1, 2023
Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response
Mihnea P Dragomir, Enrique Fuentes-Mattei, Melanie Winkle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2016
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
Katrien Van Roosbroeck, Francesca Fanini, Tetsuro Setoyama, et al.
Page
of 19